These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 121158)

  • 21. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
    Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
    Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antidepressive effects of 3 endogenous monoamines: psychopharmacologic profiles of noradrenaline, octopamine and phenethylamine].
    Bulach C; Doaré L; Massari B; Simon P
    J Pharmacol; 1984; 15(1):1-15. PubMed ID: 6425565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 26. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 Oct; 154(2):353-63. PubMed ID: 15313023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central neurotropic activity of homovanillic acid.
    Kleinrok Z; Zarkowski AM
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 32. Central action of 6-aminodopamine.
    Bień E
    Pol J Pharmacol Pharm; 1983; 35(1):7-14. PubMed ID: 6193501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central action of intraventricularly-injected midodrine in rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Oktaba-Polkowska A
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):217-33. PubMed ID: 6160823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study on the neuro-behavioral development in rats treated neonatally with drugs acting on the autonomic nervous system].
    Watanabe T; Matsuhashi K; Takayama S
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):267-82. PubMed ID: 6500402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central effects of 6-hydroxydopamine.
    Longo VG
    Behav Biol; 1973 Oct; 9(4):397-420. PubMed ID: 4200735
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of the neurotoxicity of 6-hydroxydopamine by intraneuronal noradrenaline in rat iris.
    Sachs C; Jonsson G; Heikkila R; Cohen G
    Acta Physiol Scand; 1975 Mar; 93(3):345-51. PubMed ID: 1096534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
    Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.